Squamous cell carcinoma during long term hydroxyurea treatment: A case report

BACKGROUND: Hydroxyurea (HU) is a ribonucleotide diphosphate reductase inhibitor that interferes with the S phase of cell replication and inhibits DNA synthesis, with limited or no effect on RNA or protein synthesis. The cutaneous side effects of hydroxyurea treatment are diverse and frequent. Squam...

Descripción completa

Detalles Bibliográficos
Autores principales: Kerdoud, Ouassime, Aloua, Rachid, Kaouani, Amine, Belem, Ousmane, Slimani, Faiçal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8278417/
https://www.ncbi.nlm.nih.gov/pubmed/34252640
http://dx.doi.org/10.1016/j.ijscr.2021.106160

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8278417/
https://www.ncbi.nlm.nih.gov/pubmed/34252640
http://dx.doi.org/10.1016/j.ijscr.2021.106160

Ejemplares similares